# China NMPA Drug Inspection - Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical Factory - Albendazole tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangzhou-baiyunshan-pharmaceutical-group-co-ltd-baiyunshan-pharmaceutical-factory/637c58d4-fbaf-4fbb-ab4b-0e8ad72cead3/
Source feed: China

> China NMPA drug inspection for Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical Factory published July 28, 2022. Drug: Albendazole tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical Factory
- Publication Date: 2022-07-28
- Drug Name: Albendazole tablets
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/guangzhou-baiyunshan-pharmaceutical-group-co-ltd-baiyunshan-pharmaceutical-factory/ccea4422-b643-4b8c-b0a6-781d62bb7724/